Trimbos Participates in Central Asia Drug Action Program 2015-2018
May 20, 2015
The Trimbos Institute will support governments in Central Asia in revising and renewing existing drug Strategies, action programs and drug legislation. They will use methods that were proven effective in the EU, that conform to international standards, and that meet the national needs in Central Asia.
The Central Asia Drug Action Program 2015 -2018 (CADAP 6) is funded by the European Commission. It supports five Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan) in developing the following areas:
- a consistent policy on drugs
- a monitoring system for collecting and analyzing reliable data on the nature and scope of drug-related problems
- the development of innovative and effective drug use prevention programs, and drug treatment interventions
This will require a thorough assessment and analysis of the current drug situation in these Central Asian countries. Emphasis will also be on initiating and stimulating the development of a policy that will be understood and supported by the stakeholders and the population. The program will show that developing a policy is a continuing, cyclical process. This will consist of analysis, development, implementation, and evaluation, requiring involvement of all participants.
The CADAP 6 program is being implemented under the auspices of GIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit) in cooperation with three other consortium partners from Germany, the Czech Republic, and Poland.